CAS: 1245603-92-2
| Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
|---|---|---|---|---|
 | 2-Pyrimidinecarboxamide, N,N-dimethyl-5-[[2-methyl-6-[[(5-methyl-2-pyrazinyl)amino]carbonyl]-4-benzofuranyl]oxy]- REF: IN-DA000M7CCAS: 1245603-92-2 | 99.78% | A consultar | Qua 11 Dez 24 |
 | PF 04937319 REF: 3D-VZB60392CAS: 1245603-92-2 | Min. 95% | A consultar | Qua 22 Jan 25 |
 | PF-04937319 REF: TM-T16479CAS: 1245603-92-2 | 98.61% | 45,00 €~551,00 € | Qua 12 Fev 25 |
![2-Pyrimidinecarboxamide, N,N-dimethyl-5-[[2-methyl-6-[[(5-methyl-2-pyrazinyl)amino]carbonyl]-4-ben…](https://static.cymitquimica.com/products/IN/thumb/DA000M7C.jpg)
2-Pyrimidinecarboxamide, N,N-dimethyl-5-[[2-methyl-6-[[(5-methyl-2-pyrazinyl)amino]carbonyl]-4-benzofuranyl]oxy]-
CAS:1245603-92-2
Fórmula:
C22H20N6O4
Pureza:
99.78%
Peso molecular:
432.4320
Ref: IN-DA000M7C
| 1mg | 194,00 € | ||
| 5mg | 333,00 € | ||
| 10mg | 537,00 € | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Entrega estimada em Estados Unidos, Quarta-feira 11 de Dezembro de 2024
PF 04937319
CAS:1245603-92-2
PF 04937319 is a small molecule that has been designed to inhibit the activity of …
Fórmula:
C22H20N6O4
Pureza:
Min. 95%
Peso molecular:
432.43 g/mol
Ref: 3D-VZB60392
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Entrega estimada em Estados Unidos, Quarta-feira 22 de Janeiro de 2025
PF-04937319
CAS:1245603-92-2
PF-04937319 activates glucokinase (EC50=154.4μM) with low hypoglycemia risk, researched for type 2 diabetes treatment.
Fórmula:
C22H20N6O4
Pureza:
98.61%
Cor e Forma:
Solid
Peso molecular:
432.43
Ref: TM-T16479
| 1mg | 45,00 € | ||
| 2mg | 58,00 € | ||
| 5mg | 87,00 € | ||
| 10mg | 151,00 € | ||
| 25mg | 302,00 € | ||
| 50mg | 551,00 € | ||
| 1mL*10mM (DMSO) | 96,00 € |
Entrega estimada em Estados Unidos, Quarta-feira 12 de Fevereiro de 2025
